|Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the β 4 integrin and the PI3k pathway|
P Baril, R Gangeswaran, PC Mahon, K Caulee, HM Kocher, T Harada, ...
Oncogene 26 (14), 2082-2094, 2007
|Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas|
B Terris, E Blaveri, T Crnogorac-Jurcevic, M Jones, E Missiaglia, ...
The American journal of pathology 160 (5), 1745-1754, 2002
|Expression profiling of microdissected pancreatic adenocarcinomas|
T Crnogorac-Jurcevic, E Efthimiou, T Nielsen, J Loader, B Terris, G Stamp, ...
Oncogene 21 (29), 4587-4594, 2002
|Gene expression profiles of pancreatic cancer and stromal desmoplasia|
T Crnogorac-Jurcevic, E Efthimiou, P Capelli, E Blaveri, A Baron, B Terris, ...
Oncogene 20 (50), 7437-7446, 2001
|Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism|
KL Pogue-Geile, RU Chen, MP Bronner, T Crnogorac-Jurcevic, ...
PLoS medicine 3 (12), e516, 2006
|Application of laser capture microdissection combined with two‐dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal …|
AR Shekouh, CC Thompson, W Prime, F Campbell, J Hamlett, ...
Proteomics 3 (10), 1988-2001, 2003
|Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent|
T Crnogorac‐Jurcevic, E Missiaglia, E Blaveri, R Gangeswaran, M Jones, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
|Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis|
E Missiaglia, E Blaveri, B Terris, YH Wang, E Costello, JP Neoptolemos, ...
International journal of cancer 112 (1), 100-112, 2004
|Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma|
T Crnogorac–Jurcevic, R Gangeswaran, V Bhakta, G Capurso, ...
Gastroenterology 129 (5), 1454-1463, 2005
|High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients|
D Vimalachandran, W Greenhalf, C Thompson, J Lüttges, W Prime, ...
Cancer research 65 (8), 3218-3225, 2005
|Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer|
M Akada, T Crnogorac-Jurcevic, S Lattimore, P Mahon, R Lopes, ...
Clinical Cancer Research 11 (8), 3094-3101, 2005
|Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread|
PP Wong, F Demircioglu, E Ghazaly, W Alrawashdeh, MRL Stratford, ...
Cancer cell 27 (1), 123-137, 2015
|Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility|
CC Thompson, FJ Ashcroft, S Patel, G Saraga, D Vimalachandran, ...
Gut 56 (1), 95-106, 2007
|Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer|
SE Dowen, T Crnogorac-Jurcevic, R Gangeswaran, M Hansen, ...
The American journal of pathology 166 (1), 81-92, 2005
|AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D|
L Dumartin, HJ Whiteman, ME Weeks, D Hariharan, B Dmitrovic, ...
Cancer research 71 (22), 7091-7102, 2011
|Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets|
G Capurso, S Lattimore, T Crnogorac-Jurcevic, F Panzuto, M Milione, ...
Endocrine-related cancer 13 (2), 541-558, 2006
|Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies|
C Schröder, A Jacob, S Tonack, TP Radon, M Sill, M Zucknick, S Rüffer, ...
Molecular & cellular proteomics 9 (6), 1271-1280, 2010
|The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D|
HJ Whiteman, ME Weeks, SE Dowen, S Barry, JF Timms, NR Lemoine, ...
Cancer research 67 (18), 8633-8642, 2007
|Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma|
TP Radon, NJ Massat, R Jones, W Alrawashdeh, L Dumartin, D Ennis, ...
Clinical Cancer Research 21 (15), 3512-3521, 2015
|Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2′-deoxycytidine treatment is associated with activation of the interferon signalling pathway|
E Missiaglia, M Donadelli, M Palmieri, T Crnogorac-Jurcevic, A Scarpa, ...
Oncogene 24 (1), 199-211, 2005